Literature DB >> 3884184

Determination of serum ferritin by a one-step immunoenzymoassay, and comparison of four liver-ferritin standards.

M C Revenant, J Goudable, A Beaudonnet, A Mailliavin, J Pichot, L Monnet.   

Abstract

We describe a one step "sandwich"-type immunoenzymoassay for ferritin in human serum. The solid-phase consists of glutaraldehyde-treated polypropylene tubes coated with rabbit antibody to human ferritin. Liver ferritin is the standard. Peroxidase-conjugated antiserum to ferritin and a sensitive chromogen, o-phenylenediamine, are used. The assay requires 90 min. The standard curve is linear up to 400 micrograms of ferritin per liter of serum. Within- and between-run CVs are less than 6% for low, high, and medium concentrations and are about 13.0% at the decision level for iron deficiency. Results by a two-step "sandwich" procedure (New England Immunology Associates kit) correlated well, r = 0.98. We assessed four liver ferritin standards from different manufacturers with the described method. The mean absorbance for the 40 micrograms/L ferritin standard was 1.5 for that from Diagnostics Biochem and National Institute for Biological Standards and Controls, 1.0 for that from Dako, and 0.4 for that from Sigma. Consequently, to standardize results, all liver ferritin standards should be calibrated vs the National Institute for Biological Standards and Controls reference standard.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884184

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

Review 1.  Plasma ferritin determination as a diagnostic tool.

Authors:  C A Finch; V Bellotti; S Stray; D A Lipschitz; J D Cook; M J Pippard; H A Huebers
Journal:  West J Med       Date:  1986-11

Review 2.  Performance and comparability of laboratory methods for measuring ferritin concentrations in human serum or plasma: A systematic review and meta-analysis.

Authors:  Maria N Garcia-Casal; Juan P Peña-Rosas; Eloisa Urrechaga; Jesus F Escanero; Junsheng Huo; Ricardo X Martinez; Lucero Lopez-Perez
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.